69
Views
0
CrossRef citations to date
0
Altmetric
Letters

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma: comments on the article by Danielides et al

&
Page 248 | Published online: 02 May 2012

References

  • Danielides S, Mavragani C, Katsakoulas I, Zintzaras E, Drosos A, Vlachoyiannopoulos P, . Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scand J Rheumatol 2011;40:299–303.
  • Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P, . Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis. Clin Endocrinol (Oxf) 2005;63:191–6.
  • Colin IM, Isaac J, Dupret P, Ledant T, D’Hautcourt JL. Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 2004;18:72–6.
  • Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, . Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963–70.
  • Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008;127:385–93.
  • Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, . The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009;4:e5903.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.